Barry D. Greenberg
Keine laufenden Positionen mehr
Profil
Barry D.
Greenberg is Director of Pharmacology for Bellus Health, Inc. Previously, he was a Director of Alzheimer Amyloid Research Program for Cephalon, Inc. from 1993 to 1997.
Dr. Greenberg received a PhD from the University of North Carolina and a Master's degree and a Bachelor's degree from Northwestern University.
Ehemalige bekannte Positionen von Barry D. Greenberg
| Unternehmen | Position | Ende |
|---|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | 01.01.1997 |
| BELLUS HEALTH | Corporate Officer/Principal | - |
Ausbildung von Barry D. Greenberg
| The University of North Carolina at Charlotte | Doctorate Degree |
| Northwestern University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
BELLUS Health, Inc.
 BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
